Bridgefront Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,551
| Closed | -$175K | – | 637 |
|
|
2024
Q1 | $175K | Buy |
+17,551
| New | +$175K | 0.13% | 327 |
|
|
2023
Q4 | – | Sell |
-14,490
| Closed | -$111K | – | 542 |
|
|
2023
Q3 | $111K | Buy |
+14,490
| New | +$111K | 0.08% | 354 |
|
|
2023
Q2 | – | Sell |
-14,610
| Closed | -$97.4K | – | 644 |
|
|
2023
Q1 | $97.4K | Buy |
+14,610
| New | +$97.4K | 0.06% | 391 |
|